WEDNESDAY, Sept. 29, 2022 (HealthDay News) – The Jynneos vaccine, originally designed to guard against smallpox infection, also seems to protect against monkeypox, new U.S. government data shows. The potency of the vaccine in a real-world setting was impressive: While two doses of the vaccine offered more protection against monkeypox, even people who received a…  read on >  read on >

Weight-loss surgery can change a person’s life and health, but new research warns it might also come with a slight risk of developing epilepsy. People who had the surgery had a 45% relative increased risk of developing epilepsy, compared with people who did not have the surgery. Moreover, those who suffered a stroke after weight-loss…  read on >  read on >

Folks having surgery have lots of things to worry about as they go under the knife, but the gender of their surgeon isn’t one of them, a new study finds. There’s no difference in rates of death or complications between male and female surgeons, Japanese data shows. And that’s even though in Japan female surgeons…  read on >  read on >

Smoking isn’t only costly in terms of health risks, it also cost the U.S. economy $891 billion in 2020. That was almost 10 times the cigarette industry’s $92 billion revenue, according to the authors of a new American Cancer Society study. “Economic losses from cigarette smoking far outweigh any economic benefit from the tobacco industry…  read on >  read on >

WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease. The findings from a phase 3 clinical trial have yet to be peer-reviewed in any medical journal. But according to a company news release, “lecanemab treatment…  read on >  read on >